May. 29 2024
Source Page: Topical steroids: introduction of new labelling and a reminder of the possibility of severe side effects, including Topical Steroid Withdrawal ReactionsFound: , and as stated by Broersen et al there is no administration form, treatment duration or underlying disease
Report May. 28 2024
Committee: Transport Committee (Department: Department for Transport)Found: Many of the responses mentioning toilets also mentioned specific disabilities, including Crohn’s disease
Written Evidence May. 23 2024
Inquiry: Food, Diet and ObesityFound: Effects of Full-Fat and Fermented Dairy Products on Cardiometabolic Disease: Food Is More Than the
Mentions:
1: Lord Markham (Con - Life peer) Additionally, NHS England aims to reduce variation in care for people with inflammatory bowel disease - Speech Link
2: Lord Markham (Con - Life peer) can tell with 90% sensitivity whether you have inflammatory bowel disease or irritable bowel syndrome - Speech Link
3: Lord Markham (Con - Life peer) Irritable bowel syndrome is suffered by about 10% of the population while inflammatory bowel disease—we - Speech Link
Mentions:
1: Peter Dowd (Lab - Bootle) It is the case that 153,000 people are living with Parkinson’s disease in the UK. - Speech Link
2: Maria Caulfield (Con - Lewes) Member for Bootle talked specifically about some of the work on renal disease. - Speech Link
May. 14 2024
Source Page: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]Found: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]
May. 14 2024
Source Page: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]Found: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]
May. 14 2024
Source Page: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]Found: Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]